Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Apalutamide versus bicalutamide with GnRH agonist and primary radiation therapy in high-risk prostate cancer
RBR-76cwjdPhase 3Not yet recruiting
- Sponsor
- Hospital de Amor
- Start
- Dec 2015
- Modality
- Orthosteric Ligands → Classical Binding Small Molecules → Small Molecules
- Countries
- 1
01
Overview
Phase 3, randomised, double-blind trial of apalutamide in prostate cancer (PCa) (2 arms), sponsored by Hospital de Amor. Planned start Dec 2015; status: not yet recruiting.
02
Drugs
apalutamide
03
Conditions
prostate cancer (PCa)
Beyond the preview
Go deeper on RBR-76cwjd.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on RBR-76cwjd.